These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


302 related items for PubMed ID: 2877431

  • 1. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [Abstract] [Full Text] [Related]

  • 2. [Sensitivity of anaerobes to 8 antibiotics].
    Sedallian A.
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE, Olsson-Liljequist B.
    Scand J Infect Dis Suppl; 1984 Jun; 43():44-9. PubMed ID: 6100139
    [Abstract] [Full Text] [Related]

  • 5. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B, Naden MG.
    Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
    [Abstract] [Full Text] [Related]

  • 6. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.
    Appelbaum PC, Spangler SK, Jacobs MR.
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1214-8. PubMed ID: 1929264
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [In vitro effects of cefotetan on anaerobic bacteria of the genus Bacteroides fragilis group, in comparison with 8 antibiotics].
    Trevisan R, Proietti A, Pitzus E.
    G Ital Chemioter; 1985 Jun; 32(2):367-70. PubMed ID: 3869115
    [No Abstract] [Full Text] [Related]

  • 10. Anaerobic bacteria and beta-lactam antibiotics.
    Nord CE, Olsson-Liljequist B.
    Scand J Infect Dis Suppl; 1984 Jun; 42():72-82. PubMed ID: 6335601
    [Abstract] [Full Text] [Related]

  • 11. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A, Roudon T.
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [Abstract] [Full Text] [Related]

  • 12. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].
    Dusart G, Simeon de Buochberg M, Zuccarelli M, Attisso MA, Willemin C.
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878
    [Abstract] [Full Text] [Related]

  • 13. [In vitro activity of the oxa-beta-lactam LY 127935 against Bacteroides fragilis and other anaerobic gram-negative rods (author's transl)].
    Werner H, Krasemann C.
    Infection; 1980 Jun; 8 Suppl 3():S 342-6. PubMed ID: 6447673
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [In vitro activity of 10 antibiotics including pristinamycin and its two components (RP 12536 and 27404) against strict anaerobes].
    Dubreuil L, Houcke I, Singer E.
    Pathol Biol (Paris); 1998 Feb; 46(2):147-52. PubMed ID: 9769928
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
    Lee K, Chong Y, Jeong SH, Xu XS, Kwon OH.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.
    Jacobus NV, Tally FP, Barza M, Gorbach SL.
    Clin Ther; 1980 Dec; 3(Spec Issue):34-8. PubMed ID: 6446396
    [Abstract] [Full Text] [Related]

  • 19. [In vitro activity of cefotaxime on anaerobes (author's transl)].
    Soussy CJ, Thibault M, Duval J.
    Nouv Presse Med; 1981 Feb 26; 10(8):556-8. PubMed ID: 6259592
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
    Del Bene VE, Carek PJ, Twitty JA, Burkey LJ.
    Antimicrob Agents Chemother; 1985 May 26; 27(5):817-20. PubMed ID: 3874597
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.